KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Ratio (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Equity Ratio data on record, last reported at 0.55 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 5.77% year-over-year to 0.55; the TTM value through Dec 2025 reached 0.55, down 5.77%, while the annual FY2025 figure was 0.55, 5.77% down from the prior year.
  • Equity Ratio reached 0.55 in Q4 2025 per ZBH's latest filing, up from 0.54 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.59 in Q2 2024 and bottomed at 0.52 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.56, with a median of 0.57 recorded in 2022.
  • Peak YoY movement for Equity Ratio: rose 11.25% in 2021, then fell 7.47% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.54 in 2021, then increased by 5.73% to 0.57 in 2022, then rose by 1.75% to 0.58 in 2023, then rose by 0.52% to 0.58 in 2024, then fell by 5.77% to 0.55 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.55 in Q4 2025, 0.54 in Q3 2025, and 0.55 in Q2 2025.